NeoGenomics, Inc.
(NASDAQ : NEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
EVHCEnvision Healthcare Holdings, Inc.
-0.16%44.967.9%$77.94m
DVADaVita HealthCare Partners Inc.
-0.51%72.502.3%$74.81m
AMEDAmedisys, Inc.
1.50%119.3011.7%$51.52m
CHEChemed Corporation
0.44%318.3410.0%$39.59m
ACHCAcadia Healthcare Company, Inc.
1.01%39.1927.3%$38.31m
MDMEDNAX, Inc.
-0.76%46.7310.1%$37.83m
LHCGLHC Group, Inc.
0.01%93.842.8%$22.05m
ADUSAddus HomeCare Corporation
2.23%59.601.3%$11.57m
NEONeoGenomics, Inc.
0.96%12.677.7%$10.31m
ENSGEnsign Group, Inc.
-0.16%37.176.0%$8.62m
USPHU.S. Physical Therapy, Inc.
0.66%114.254.8%$6.41m
FMSFresenius Medical Care AG & Co. KGaA Sponsored ADR
0.54%48.470.1%$6.17m
RDNTRadNet, Inc.
0.00%14.100.5%$2.14m
COChina Cord Blood Corporation
0.27%7.310.3%$1.57m
AIQAlliance HealthCare Services, Inc.
0.34%15.200.5%$0.43m

Company Profile

NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. The company operates through one segment: Laboratory Testing Segment. The Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.